Journals / Afyon Kocatepe Üniversitesi Fen ve Mühendislik Bilimleri Dergisi / 2016 / Cilt: 16 - Sayı: 2

N‐Aril‐N'‐Heteroaril‐Substitue Üre Türevlerinin Sentezi

Pages
222–229
Publication Date
2016-04-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Bu çalışmada, biyolojik aktif bileşikler grubunda yer alan benzimidazol, tiyazol ve üre grubunu aynı

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Bu çalışmada, biyolojik aktif bileşikler grubunda yer alan benzimidazol, tiyazol ve üre grubunu aynı
📊
Key Findings & Data:Bu çalışmada, biyolojik aktif bileşikler grubunda yer alan benzimidazol, tiyazol ve üre grubunu aynı
💡
Conclusion & Impact:Bu çalışmada, biyolojik aktif bileşikler grubunda yer alan benzimidazol, tiyazol ve üre grubunu aynı
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Benzimidazol · Üre · Tiyazol

Özet

Bu çalışmada, biyolojik aktif bileşikler grubunda yer alan benzimidazol, tiyazol ve üre grubunu aynı

🔖

Cite This Article

DOĞAN, Ş. D. (2016). N‐Aril‐N'‐Heteroaril‐Substitue Üre Türevlerinin Sentezi. Afyon Kocatepe Üniversitesi Fen ve Mühendislik Bilimleri Dergisi, Cilt: 16 - Sayı: 2, 222–229. https://ajindex.com/articles/451594

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Allen D. R., A. Bolt, G. A. Chapman, R. L. Knight, J. W. G. Meissner, D. A. Owen and R. J. Watson (2007). Identification and structure–activity relationships of 1‐aryl‐3‐piperidin‐4‐yl‐urea derivatives as CXCR3 receptor antagonists, Bioorganic & Medicinal Chemistry Letters 17(3): 697‐701. Ansari K. F. and C. Lal (2009). Synthesis and evaluation of some new benzimidazole derivatives as potential antimicrobial agents, European Journal of Medicinal Chemistry 44(5): 2294‐2299. Budriesi R., P. Ioan, A. Locatelli, S. Cosconati, A. Leoni, M. P. Ugenti, A. Andreani, R. Di Toro, A. Bedini, S. Spampinato, L. Marinelli, E. Novellino and A. Chiarini (2008). Imidazo[2,1‐ b]thiazole System: A Scaffold Endowing Dihydropyridines with Selective Cardiodepressant Activity, Journal of Medicinal Chemistry 51(6): 1592‐1600. Cole A. G., I. L. Stroke, M.‐R. Brescia, S. Simhadri, J. J. Zhang, Z. Hussain, M. Snider, C. Haskell, S. Ribeiro, K. C. Appell, I. Henderson and M. L. Webb (2006). Identification and initial evaluation of 4‐N‐aryl‐[1,4]diazepane ureas as potent CXCR3 antagonists, Bioorganic & Medicinal Chemistry Letters 16(1): 200‐203. Dai Y., K. Hartandi, Z. Ji, A. A. Ahmed, D. H. Albert, J. L. Bauch, J. J. Bouska, P. F. Bousquet, G. A. Cunha and K. B. Glaser (2007). Discovery of N‐(4‐(3‐Amino‐1 Hindazol‐ 4‐yl) phenyl)‐N'‐(2‐fluoro‐5‐ methylphenyl) urea (ABT‐869), a 3‐ Aminoindazole‐Based Orally Active Multitargeted Receptor Tyrosine Kinase Inhibitor, Journal of medicinal chemistry 50(7): 1584‐1597. de Oliveira Lopes R., N. C. Romeiro, C. K. F. de Lima, L. L. da Silva, A. L. P. de Miranda, P. G. B. Nascimento, F. Q. Cunha, E. J. Barreiro and L. M. Lima (2012). Docking, synthesis and pharmacological activity of novel ureaderivatives designed as p38 MAPK inhibitors, European journal of medicinal chemistry 54: 264‐271. Demain A. L. and S. Sanchez (2009). Microbial drug discovery: 80 years of progress, The Journal of antibiotics 62(1): 5‐16. Doğan S. D., E. Demirpolat, M. B. Y. Aycan and M. Balci (2015). Synthesis of new 4‐azaindoles via acyl azides, Tetrahedron 71(2): 252‐258. Garudachari B., M. N. Satyanarayana, B. Thippeswamy, C. K. Shivakumar, K. N. Shivananda, G. Hegde and A. M. Isloor (2012). Synthesis, characterization and antimicrobial studies of some new quinoline incorporated benzimidazole derivatives, European Journal of Medicinal Chemistry 54: 900‐906. Hodge C. N., P. E. Aldrich, L. T. Bacheler, C.‐H. Chang, C. J. Eyermann, S. Garber, M. Grubb, D. A. Jackson, P. K.